Journal Report

Amyloid

Download PDF
Journal Information
Journal Title
Amyloid
Publisher
Taylor and Francis Ltd.
ISSN
1350-6129
E-ISSN
1744-2818
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Operational definitions of the asymptomatic <i>TTR</i> variant carrier: a methodological framework for ATTRv amyloidosis polyneuropathy research
Isabel Conceição, José Castro, Mamede de Carvalho
2026-11-3 Pages 1-4
DOI: 10.1080/13506129.2026.2752854
Robert A. Kyle: In Memoriam
Shaji K. Kumar, Morie A. Gertz
2026-11-1 Pages 1-2
DOI: 10.1080/13506129.2026.2754630
Prevalence and prognostic impact of valvular heart disease in transthyretin cardiac amyloidosis
Camille Sarrazyn, Philippe Debonnaire, Mathias Claeys et al.
2026-10-29 Pages 1-13
DOI: 10.1080/13506129.2026.2746736
Ixazomib maintenance for the treatment of light chain AL amyloidosis
Caitlin Sarubbi, Hani Hassoun, Grace Gallagher et al.
2026-10-29 Pages 1-4
DOI: 10.1080/13506129.2026.2740037
Quality standards for the diagnosis and management of ATTR and AL amyloidosis: a nominal group technique study
Laura Obici, Thibaud Damy, Lucia Galan et al.
2026-10-21 Pages 1-15
DOI: 10.1080/13506129.2026.2743072
Multiple musculoskeletal procedures over time and the risk of amyloidosis: a Danish nationwide cohort study
Navid Noory, Peter L. Graversen, Eva Havers-Borgersen et al.
2026-10-20 Pages 1-4
DOI: 10.1080/13506129.2026.2748887
Full-length light chain sequencing refocuses attention on the constant domain in AL amyloidosis
Luis del Pozo-Yauner
2026-10-15 Pages 1-3
DOI: 10.1080/13506129.2026.2747712
Childhood onset, indolent progression, and risk of hepatic rupture: the natural history of hereditary lysozyme amyloidosis
Jack E. Carruthers, Janet A. Gilbertson, Dorota Rowczenio et al.
2026-10-12 Pages 1-9
DOI: 10.1080/13506129.2026.2735580
Emerging therapies and translational tools for drug development in systemic amyloidosis: insights from the International Society of Amyloidosis Scientific Workshop
Gareth J. Morgan, Angela Dispenzieri, Jing Fu et al.
2026-10-5 Pages 1-14
DOI: 10.1080/13506129.2026.2735581
Treatment of Waldenström macroglobulinemia associated with AL amyloidosis with teclistamab: a case report
Yang Liu, Yue Hu, Jingyi Bi et al.
2026-10-5 Pages 1-4
DOI: 10.1080/13506129.2026.2740737
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 5, 2026 02:11